High-dose versus standard-dose radiotherapy with concurrent chemotherapy in stages II-III esophageal cancer.
about
Clinical features, outcomes and treatment-related pneumonitis in elderly patients with esophageal carcinoma.Long-term results of chemoradiotherapy for stage II-III thoracic esophageal cancer in a single institution after 2000 -with a focus on comparison of three protocolsAssociated factors of radiation pneumonitis induced by precise radiotherapy in 186 elderly patients with esophageal cancer.Preliminary treatment results of proton beam therapy with chemoradiotherapy for stage I-III esophageal cancer.High-dose versus conventional-dose irradiation in cisplatin-based definitive concurrent chemoradiotherapy for esophageal cancer: a systematic review and pooled analysis.Chemoradiotherapy for T4 and/or M1 lymph node esophageal cancer: experience since 2000 at a high-volume center in Japan.Prognostic value of supraclavicular nodes and upper abdominal nodes metastasis after definitive chemoradiotherapy for patients with thoracic esophageal squamous cell carcinoma.What is the optimal radiation dose for non-operable esophageal cancer? Dissecting the evidence in a meta-analysis.Improved survival with higher radiation dose for esophageal squamous cell carcinoma patients treated with definitive chemoradiotherapy.Neoadjuvant versus definitive chemoradiotherapy for locally advanced esophageal cancer : Outcomes and patterns of failure.Radiotherapy for esophageal carcinoma: dose, response and survival.Dose-Response Relationship between Radiation Dose and Loco-regional Control in Patients with Stage II-III Esophageal Cancer Treated with Definitive Chemoradiotherapy.Advances in radiotherapy for esophageal cancer.Standard-dose versus high-dose radiotherapy with concurrent chemotherapy in esophageal cancer: A prospective randomized study.Clinical Effect of Radiotherapy Combined with Chemotherapy for Non-Surgical Treatment of the Esophageal Squamous Cell Carcinoma.Dose-escalated radiotherapy improved survival for esophageal cancer patients with a clinical complete response after standard-dose radiotherapy with concurrent chemotherapy
P2860
Q34255601-64AB691B-872F-4E5C-917C-3112D3CF39A2Q35823373-D50461AD-7DEA-4AE4-B0DF-5F6575504204Q36318126-B0F6E181-6281-4153-8627-6CBBC276DE3AQ36706857-CDAB054B-941F-44B1-A6AF-9F046B8DBEEBQ38559388-B9C1E907-F946-4A3B-B5AA-21293DDC902BQ38577792-D62E7343-CF07-4270-850D-16735DBF65E1Q42371515-CACCF639-A6C0-4944-AB36-174F4FB54FA4Q47142547-D3CE0983-FF3B-4597-B1DD-D3ABDC3DAF12Q47161120-07C6FE3D-EC07-456B-A9C9-7FDA3E4047DBQ48336173-B9AF2AFC-34DF-4B22-B3EA-3C66986AED4AQ49166159-63B39A95-BFD7-4726-8B8F-963C9C830483Q49199019-C00CB3CA-675C-4F54-9531-F2500B0759F6Q55280639-6E2EC2F0-7692-4741-B5FA-B6950AEFB5D6Q55286764-4BDF3E69-475B-49FE-AB0D-7F194482AD4EQ55564006-7E68762F-9469-4E6E-A860-0BB3090707E1Q58781949-A800B3E3-5E14-4083-88C9-6701152889D8
P2860
High-dose versus standard-dose radiotherapy with concurrent chemotherapy in stages II-III esophageal cancer.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
High-dose versus standard-dose ...... ages II-III esophageal cancer.
@en
High-dose versus standard-dose ...... ages II-III esophageal cancer.
@nl
type
label
High-dose versus standard-dose ...... ages II-III esophageal cancer.
@en
High-dose versus standard-dose ...... ages II-III esophageal cancer.
@nl
prefLabel
High-dose versus standard-dose ...... ages II-III esophageal cancer.
@en
High-dose versus standard-dose ...... ages II-III esophageal cancer.
@nl
P2093
P2860
P356
P1476
High-dose versus standard-dose ...... ages II-III esophageal cancer.
@en
P2093
Ik Jae Lee
Jong Young Lee
Soo Kon Kim
Wong Sub Koom
Yang-Gun Suh
P2860
P304
P356
10.1093/JJCO/HYU047
P577
2014-04-24T00:00:00Z